CLINICAL-TRIALS OF WR-2721 PRIOR TO ALKYLATING AGENT CHEMOTHERAPY AND RADIOTHERAPY

被引:63
作者
GLOVER, D
FOX, KR
WEILER, C
KLIGERMAN, MM
TURRISI, A
GLICK, JH
机构
[1] UNIV PENN,DEPT RADIAT THERAPY,PHILADELPHIA,PA 19104
[2] UNIV PENN,CTR CANC,PHILADELPHIA,PA 19104
关键词
D O I
10.1016/0163-7258(88)90032-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:3 / 7
页数:5
相关论文
共 28 条
[1]   THE USE OF DRUGS WHICH DEPLETE INTRACELLULAR GLUTATHIONE IN HYPOXIC CELL RADIOSENSITIZATION [J].
BUMP, EA ;
YU, NY ;
BROWN, JM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (3-4) :439-442
[2]   PHASE-I CONTROLLED TRIALS OF WR-2721 AND CYCLOPHOSPHAMIDE [J].
GLICK, JH ;
GLOVER, D ;
WEILER, C ;
NORFLEET, L ;
YUHAS, J ;
KLIGERMAN, MM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1984, 10 (09) :1777-1780
[3]   PHASE-I TRIALS OF WR-2721 AND CIS-PLATINUM [J].
GLOVER, D ;
GLICK, JH ;
WEILER, C ;
YUHAS, J ;
KLIGERMAN, MM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1984, 10 (09) :1781-1784
[4]   HYPOCALCEMIA AND INHIBITION OF PARATHYROID-HORMONE SECRETION AFTER ADMINISTRATION OF WR-2721 (A RADIOPROTECTIVE AND CHEMOPROTECTIVE AGENT) [J].
GLOVER, D ;
RILEY, L ;
CARMICHAEL, K ;
SPAR, B ;
GLICK, J ;
KLIGERMAN, MM ;
AGUS, ZS ;
SLATOPOLSKY, E ;
ATTIE, M ;
GOLDFARB, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (19) :1137-1141
[5]   WR-2721 PROTECTS AGAINST THE HEMATOLOGIC TOXICITY OF CYCLOPHOSPHAMIDE - A CONTROLLED PHASE-II TRIAL [J].
GLOVER, D ;
GLICK, JH ;
WEILER, C ;
HUROWITZ, S ;
KLIGERMAN, MM .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (04) :584-588
[6]   PHASE I/II TRIALS OF WR-2721 AND CISPLATINUM [J].
GLOVER, D ;
GLICK, JH ;
WEILER, C ;
FOX, K ;
TURRISI, A ;
KLIGERMAN, MM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (08) :1509-1512
[7]   WR-2721 AND HIGH-DOSE CISPLATIN - AN ACTIVE COMBINATION IN THE TREATMENT OF METASTATIC MELANOMA [J].
GLOVER, D ;
GLICK, JH ;
WEILER, C ;
FOX, K ;
GUERRY, D .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (04) :574-578
[8]   TREATMENT OF HYPERCALCEMIA IN PARATHYROID CANCER WITH WR-2721, S-2-(3-AMINOPROPYLAMINO) ETHYL-PHOSPHOROTHIOIC ACID [J].
GLOVER, DJ ;
SHAW, L ;
GLICK, JH ;
SLATOPOLSKY, E ;
WEILER, C ;
ATTIE, M ;
GOLDFARB, S .
ANNALS OF INTERNAL MEDICINE, 1985, 103 (01) :55-57
[9]  
GROCHOW LB, 1980, CLIN PHARMACOKINET, V4, P380
[10]   RADIOBIOLOGICAL AND BIOCHEMICAL STUDIES OF THIOPHOSPHATE RADIOPROTECTIVE COMPOUNDS RELATED TO CYSTEAMINE [J].
HARRIS, JW ;
PHILLIPS, TL .
RADIATION RESEARCH, 1971, 46 (02) :362-&